Drug-induced sleep endoscopy: A new gold standard for evaluating OSAS? Part II: Results

M Blumen; E Bequignon; F Chabolle

doi:10.1016/j.anorl.2016.12.004

Drug-induced sleep endoscopy: A new gold standard for evaluating OSAS? Part II: Results

Eur Ann Otorhinolaryngol Head Neck Dis. 2017 Apr;134(2):109-115. doi: 10.1016/j.anorl.2016.12.004. Epub 2017 Mar 6.

Authors

M Blumen¹, E Bequignon², F Chabolle³

Affiliations

¹ Service ORL, hôpital Foch, 40, rue Worth, 92140 Suresnes, France; Centre médical Veille-Sommeil, 59, avenue de Villiers, 75017 Paris, France. Electronic address: blumen@cmvs.fr.
² Service ORL, hôpital Mondor, 51, avenue du Général-de-Lattre-de-Tassigny, 94000 Créteil, France.
³ Service ORL, hôpital Foch, 40, rue Worth, 92140 Suresnes, France.

PMID: 28279632
DOI: 10.1016/j.anorl.2016.12.004

Abstract

Surgical results in obstructive sleep apnea syndrome (OSAS) vary greatly, whatever the surgical technique or site. Most authors agree that rigorous patient selection is logical and mandatory. Drug-induced sleep endoscopy (DISE) was introduced in 1991 and has been rediscovered and used extensively since the 2000s. It attempts to mimic natural sleep in order to observe the upper airway on flexible endoscopy in a situation in which obstruction may occur. A review of the DISE literature was performed, and is reported in two parts. The present second part reports DISE results concerning obstruction sites, impact on treatment efficacy and the consequent indications for this exploration.

Keywords: Diagnosis; Drug-induced sleep endoscopy; Exploration; Obstructive sleep apnea syndrome; Snoring.

Publication types

Review

MeSH terms

Endoscopy* / instrumentation
Endoscopy* / methods
Humans
Hypnotics and Sedatives / administration & dosage*
Patient Selection
Polysomnography*
Sleep Apnea, Obstructive / diagnosis*
Sleep Apnea, Obstructive / etiology
Sleep Apnea, Obstructive / therapy*
Treatment Outcome

Substances

Hypnotics and Sedatives